Telegram-Icon YouTube-Icon Instagram-Icon

Loading IST...
28 Jan
Open Date Open
30 Jan
Close Date Close
2 Feb
Allotment Date Allotment
4 Feb
Today, 4 February 2026 (IST)
Listing Date Listing

Accretion Nutraveda IPO is an SME IPO with Fresh issue only and Book Built Issue. The company will raise upto 24 crore 76 lakh 80 thousand for 19,20,000 shares from the IPO. The IPO issue size is 19,20,000 shares (aggregating up to 24 crore 76 lakh 80 thousand), fresh issue: 19,20,000 shares (aggregating up to 24 crore 76 lakh 80 thousand) and offer for sale: NIL.
is the lead manager and Kfin Technologies Ltd is the registrar of IPO.

The IPO will open for subscription on 28 January 2026 and close on 30 January 2026. The basis of allotment will be decided on 2 February 2026 and Accretion Nutraveda IPO shares will be listed on 4 February 2026 at BSE SME.

Price band for IPO is ₹122 to ₹129 per share, minimum and maximum amount required for retail investor is ₹2,58,000 (2,000 shares, 2 lots), minimum amount required for sHni investor is ₹3,87,000 (3,000 shares, 3 lots) and maximum amount for which shni investor can apply for is ₹9,03,000 (7,000 shares, 7 lots). Minimum amount required for bHni investor is ₹10,32,000 (8,000 shares, 8 lots).

Accretion Nutraveda IPO Details, Price, Market Lot

Accretion Nutraveda IPO Details
IPO Open Date
IPO Close Date
IPO Issue Size
Issue (Sale Type)
Fresh Issue
Offer for Sale
Offered to Public
Reserved for Market Maker
Market Maker
Share Holding (Pre Issue)
Share Holding (Post Issue)
Listing At
Accretion Nutraveda IPO Price
has set a price band of , lot size is of and face value is .
Face Value
Price Band
₹122 to ₹129 per share
Lot Size
1,000 shares
IPO Issue Type
Accretion Nutraveda IPO Time Table
IPO will open for subscription on and close on . Basis of Allotment will be decided on , initiation of refund will begin on and IPO will be listed on at .
IPO Open Date
IPO Close Date
Basis of Allotment Date
Initiation of Refunds
Credit of Share to Demat Account
IPO Listing Date
IPO Cut-off time (UPI mandate confirmation)
Accretion Nutraveda IPO Reservation
Total shares offered by IPO is . Out of which is reserved for retail, is reserved for HNI (NII), is reserved for QIB, and is reserved for market maker .
Retail Quota
NII Quota
QIB Quota
Market Maker Quota
Total
Company Promotor & Promotor's Holding
The promoters of company are Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr.
Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod and Mr.
Vivek Ashok Kumar Patel.
Pre Issue Promotor Holding
Post Issue Promotor Holding
Accretion Nutraveda IPO Registrar
Accretion Nutraveda IPO Lead Manager
is the book running lead manager, is the registrar and the market maker of the IPO
IPO Financial Indicator (valuations)
Market Capitalization
Debt/Equity
ROE
ROCE
RONW
P/BV
PAT Margin
EBITDA
Accretion Nutraveda IPO P/E ratio and EPS
EPS (Pre IPO)
EPS (Post IPO)
P/E ratio (Pre IPO)
P/E ratio (Post IPO)

Accretion Nutraveda IPO Lot Size and Required Amount

has set a price band of and lot size is of . Retail investors can bid for a minimum and maximum of lots ( shares), requiring an investment of . Small HNI (sHNI) investors can bid for a minimum of lots ( shares), requiring an investment of and maximum of lots ( shares), requiring an investment of . Big HNI (bids > 10 Lakh, bHNI) investors can bid for a minimum of Lots ( shares), requiring an investment of . Calculated at the cut-off price (the upper end of the price band).

Number of Shares Per Lot =
Application Lot(s) Shares Amount
Retail (Minimum)
Retail (Maximum)
S-HNI (Minimum)
S-HNI (Maximum)
B-HNI (Minimum)
Number of Shares Per Lot =
Application Lot(s) Shares Amount
Retail (Min)
Retail (Max)
S-HNI (Min)
S-HNI (Max)
B-HNI (Min)

Accretion Nutraveda Financials

Accretion Nutraveda SME Financials
Annual Performance (31 Mar 25 vs 31 Mar 24)
Accretion Nutraveda SME's Assets increased by 134.1%, Revenue increased by 208.8%, Profit After Tax increased by 218.3%, EBITDA increased by 201.7%, Net Worth increased by 395.4%, Total Borrowing increased by 77.9%, Reserves & Surplus increased by 575% compared to the previous financial year.
Assets
▲ 134.1% (6.22)
Revenue
▲ 208.8% (10.86)
Profit After Tax
▲ 218.3% (1.79)
EBITDA
▲ 201.7% (2.44)
Net Worth
▲ 395.4% (4.27)
Total Borrowing
▲ 77.9% (1.69)
Reserves & Surplus
▲ 575% (4.14)

Previous Financial Year Growth (31 Mar 24 vs 31 Mar 23)
Comparing 31 Mar 24 with 31 Mar 23, Assets increased by 14.3%, Revenue increased by 69.4%, Profit After Tax increased by 192.9%, EBITDA increased by 105.1%, Net Worth increased by 315.4%, Total Borrowing increased by 10.2%, Reserves & Surplus increased by 820%.
Assets (Prev Yr)
▲ 14.3% (0.58)
Revenue (Prev Yr)
▲ 69.4% (2.13)
Profit After Tax (Prev Yr)
▲ 192.9% (0.54)
EBITDA (Prev Yr)
▲ 105.1% (0.62)
Net Worth (Prev Yr)
▲ 315.4% (0.82)
Total Borrowing (Prev Yr)
▲ 10.2% (0.2)
Reserves & Surplus (Prev Yr)
▲ 820% (0.82)

2-Year Performance Change (31 Mar 23 To 31 Mar 25)
Between 31 Mar 25 and 31 Mar 23, Assets increased by 167.5%, Revenue increased by 423.1%, Profit After Tax increased by 832.1%, EBITDA increased by 518.6%, Net Worth increased by 1957.7%, Total Borrowing increased by 95.9%, Reserves & Surplus increased by 4960%.
Assets (2-Yr Change)
▲ 167.5% (6.8)
Revenue (2-Yr Change)
▲ 423.1% (12.99)
Profit After Tax (2-Yr Change)
▲ 832.1% (2.33)
EBITDA (2-Yr Change)
▲ 518.6% (3.06)
Net Worth (2-Yr Change)
▲ 1957.7% (5.09)
Total Borrowing (2-Yr Change)
▲ 95.9% (1.89)
Reserves & Surplus (2-Yr Change)
▲ 4960% (4.96)
  31 Mar 25 In Cr. 31 Mar 24 In Cr. 31 Mar 23 In Cr.
Assets 10.86 4.64 4.06
Revenue 16.06 5.2 3.07
Profit After Tax 2.61 0.82 0.28
EBITDA 3.65 1.21 0.59
Net Worth 5.35 1.08 0.26
Total Borrowing 3.86 2.17 1.97
Reserves & Surplus 4.86 0.72 -0.1

Accretion Nutraveda IPO Listed Peer Comparison

Company NameP/E ratioEPS (Basic)EPS (Diluted)NAV (per share)RoNW (%)P/BV
Influx Healthtech Ltd46.99(Influx)4.81(Influx)4.81(Influx)38.98(Influx)11.10(Influx)5.95(Influx)
Walpar Nutritions Ltd3.30(Walpar)1.06(Walpar)1.06(Walpar)17.05(Walpar)6.24(Walpar)2.65(Walpar)
Accretion Nutraveda Ltd(Accretion)4.73(Accretion)4.73(Accretion)16.74(Accretion)56.50(Accretion)(Accretion)

Objects of the Issue

The net proceeds are proposed to be utilized in accordance with the details provided in the table below:

S.NO Purpose Net Proceeds
1 Purchase of Machineries for Automation in existing Manufacturing unit 4.22
2 Purchase of Machineries for New Manufacturing Setup 8.03
3 Funding working capital requirements of our company 5.50
4 General corporate purposes
5 Total

Accretion Nutraveda IPO Subscription Status

Loading Latest IPO Data...

Contact & Address
Address:
Phone:
Email:
Website:
IPO Prospectus

Accretion Nutraveda IPO FAQs

Accretion Nutraveda IPO is an SME IPO. The company will raise upto 24 crore 76 lakh 80 thousand for 19,20,000 shares. Face value is ₹10 per share, Price band is ₹122 to ₹129 per share, and cutt off price is ₹129 per share. The IPO opens on 28 January 2026 and closes on 30 January 2026. Kfin Technologies Ltd is the registrar and shares of Accretion Nutraveda IPO will be listed at BSE SME.

The issue size of IPO is 19,20,000 shares (aggregating up to 24 crore 76 lakh 80 thousand). For fresh issue: 19,20,000 shares (aggregating up to 24 crore 76 lakh 80 thousand) and for offer for sale: NIL.

Price band for IPO is ₹122 to ₹129 per share.

The lot size of Accretion Nutraveda IPO is of 1000. Minimum order quantity for retail investor is 2,000 shares (2 lots) and required amount is ₹2,58,000. Minimum order quantity for sHNI is 3,000 shares ( lots) and required amount is ₹3,87,000. Minimum order quantity for bHNI investor is 8,000 shares ( lots) and required amount is ₹10,32,000.

The investors portion reserved for QIB is 9,08,000 shares (47.29%), reserved for HNI is 2,76,000 shares (14.37%) and 6,40,000 shares (33.33%) reserved for retail investors.

The IPO will be available for subscription from 28 January 2026 to 30 January 2026. IPO open date is 28 January 2026 and close date is 30 January 2026.

Allotment date for IPO is 2 February 2026. On the allotment date, after the IPO allotment status is announced, investors can check their IPO application allotment status on their respective IPO registrar.

The registrar for IPO is Kfin Technologies Ltd.

The IPO will be listed on 4 February 2026 at BSE SME.